Skip to search formSkip to main contentSkip to account menu

levomilnacipran

Known as: (1S,2R)-milnacipran 
National Institutes of Health

Related topics

Related topics

5 relations
24 HR levomilnacipran 20 MG Extended Release Oral Capsule [Fetzima]24 HR levomilnacipran 80 MG Extended Release Oral Capsule

Narrower (2)

Fetzimalevomilnacipran hydrochloride

Broader (1)

milnacipran

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Cortical thickness increases with levomilnacipran treatment in a pilot randomised double‐blind placebo‐controlled trial in late‐life depression
Late‐life depression (LLD) is associated with significant medical comorbidity, cognitive impairment, and suboptimal treatment… 
2019
2019
Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double‐blind, placebo‐controlled study
Levomilnacipran extended release (ER) is a serotonin and norepinephrine reuptake inhibitor approved for major depressive disorder… 
Review
2018
Review
2018
Efficacy and tolerability of different doses of three new antidepressants for treating major depressive disorder: A PRISMA-compliant meta-analysis.
2016
2016
Effects of levomilnacipran extended-release on motivation/energy and functioning in adults with major depressive disorder
The objective of this post-hoc analysis was to investigate the relationship between motivation/energy and functional impairment… 
Review
2016
Review
2016
Inclusion/exclusion criteria in placebo-controlled studies of vortioxetine: Comparison to other antidepressants and implications for product labeling.
Review
2016
Review
2016
LEVOMILNACIPRAN--A SUCCESSOR OF MILNACIPRAN WITH A HIGHER NORADRENERGIC SELECTIVITY.
A new antidepressant, levomilnacipran, is the levorotatory enantiomer of milnacipran. The drug belongs to selective serotonin… 
2016
2016
Effects of levomilnacipran ER on fatigue symptoms associated with major depressive disorder
The aim of this study was to evaluate the effects of levomilnacipran extended-release (ER) on depression-related fatigue in… 
Review
2015
Review
2015
Prescriber's Guide to Using 3 New Antidepressants: Vilazodone, Levomilnacipran, Vortioxetine
[ILLUSTRATION OMITTED] How do they work? What makes them different? And which patients might benefit most from taking them? With… 
2014
2014
Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials
Introduction/Objective Post hoc analyses were conducted to evaluate the efficacy of levomilnacipran extended-release (ER) in… 
Review
2014
Review
2014
Levomilnacipran: A New Serotonin-Norepinephrine Reuptake Inhibitor for the Treatment of Major Depressive Disorder.
OBJECTIVE To provide a clinical overview of the antidepressant levomilnacipran. DATA SOURCES Articles were identified by… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)